Ameriprise’s Asensus Surgical, Inc. ASXC Stock Holding History

Ameriprise’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,625	Closed	-$21K	–	3775
2019 Q3	$21K	Buy	2,625 +1,630	+164%	+$22.2K	﹤0.01%	3684
2019 Q2	$18K	Sell	995 -26,592	-96%	-$582K	﹤0.01%	3703
2019 Q1	$853K	Buy	27,587 +11,193	+68%	+$375K	﹤0.01%	3100
2018 Q4	$481K	Buy	16,394 +14,753	+899%	+$670K	﹤0.01%	3202
2018 Q3	$123K	Buy	1,641 +162	+11%	+$11K	﹤0.01%	3607
2018 Q2	$80K	Sell	1,479 -65	-4%	-$2.37K	﹤0.01%	3582
2018 Q1	$34K	Buy	1,544 +515	+50%	+$11.8K	﹤0.01%	3599
2017 Q4	$26K	Buy	+1,029	New	+$31.7K	﹤0.01%	3612
2014 Q4	–	Sell	-12	Closed	-$1K	–	4496
2014 Q3	$1K	Buy	12 +4	+50%	+$216	﹤0.01%	5598
2014 Q2	$1K	Buy	+8	New	+$462	﹤0.01%	5394

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise's ASXC Position: Q4 2019 in Review

Ameriprise sold out of Asensus Surgical, Inc. (ASXC) in Q4 2019, closing a stake of 2,625 shares — an estimated $21K sold.

Ameriprise first reported a position in ASXC in Q2 2014 and held it in 10 quarters. The position peaked at $853K in Q1 2019. 81 funds tracked by Wall St. Rank hold ASXC as of Q4 2019.

Ameriprise reported no remaining Asensus Surgical, Inc. position as of Q4 2019 after selling out during the quarter.
Ameriprise sold 2,625 Asensus Surgical, Inc. shares in Q4 2019, an estimated $21K.
Ameriprise first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 10 quarters.
Ameriprise's Asensus Surgical, Inc. position peaked at $853K in Q1 2019.
81 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2019.

Based on Ameriprise's 13F filing for Q4 2019, filed 14 Feb 2020.